PUBLICATIONS · 31166680
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2019 Aug 15
- First author
- Robert C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Strahlenther Onkol. 2019 Oct;195(10):940-942. doi: 10.1007/s00066-019-01504-y.
- note
- Source null
- related pmid
- 31418045
- relationship
- Comment in
Authors and identifiers
- name
- Robert C
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Stroyakovskiy D
- type
- Author
- name
- Karaszewska B
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Levchenko E
- type
- Author
- name
- Chiarion Sileni V
- type
- Author
- name
- Schachter J
- type
- Author
- name
- Garbe C
- type
- Author
- name
- Bondarenko I
- type
- Author
- name
- Gogas H
- type
- Author
- name
- Mandalá M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Robert C
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Stroyakovskiy D
- type
- Author
- name
- Karaszewska B
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Levchenko E
- type
- Author
- name
- Chiarion Sileni V
- type
- Author
- name
- Schachter J
- type
- Author
- name
- Garbe C
- type
- Author
- name
- Bondarenko I
- type
- Author
- name
- Gogas H
- type
- Author
- name
- Mandalá M
- type
- Author
- bibliography ids
- nci-bib-aa51dc84463344f13339e502
- book metadata
- content sha256
- 27aecc6df8fa527201d5a30021014b7b272b5c168c4440fb757bb2cab7d2d152
- document type
- citation
- dois
- 10.1056/NEJMoa1904059
- electronic publication date
- display
- 2019 Jun 4
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31166680
- immutable id
- pubmed:31166680@27aecc6df8fa527201d5a30021014b7b272b5c168c4440fb757bb2cab7d2d152
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 7
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 626-636
- volume
- 381
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Strahlenther Onkol. 2019 Oct;195(10):940-942. doi: 10.1007/s00066-019-01504-y.
- note
- Source null
- related pmid
- 31418045
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 31166680
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- 4d0cecc0f0095e57f4e1914e717af420b7a204a2f433ca921751a6d177296715
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Aug 15
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle